Generation of safe and efficient, off-the-shelf, chimeric antigen receptor (CAR)-engineered T cells for broad application

Kenneth C Anderson

Molecular Sequelae of Myeloma-Bone Marrow Interactions: Therapeutic Applications

Multiple myeloma and immunoproliferative diseases

Hematology and hematologic malignancies Pathology

Jonathan Hofmann

Reproductive Factors and Risk of Multiple Myeloma and Immunoproliferative Diseases in the International Multiple Myeloma and Immunoproliferative Diseases Consortium

Multiple myeloma and immunoproliferative diseases

Hematology and hematologic malignancies Pathology

Irene M. Ghobrial

Stroma-mediated clonal evolution in Multiple Myeloma

Multiple myeloma and immunoproliferative diseases

Linda J Burns

Training and Mentorship of Hematologic Oncologists

Non-Hodgkin lymphoma Multiple myeloma and immunoproliferative diseases Leukaemia Hodgkin lymphoma

Hematology and hematologic malignancies

Ratneshwar Lal

Amyloid ion channels to design therapeutics for neurodegenerative diseases

Multiple myeloma and immunoproliferative diseases

Pathology

Clark W Distelhorst

Bcl-2 Function on the Endoplasmic Reticulum

Non-Hodgkin lymphoma Multiple myeloma and immunoproliferative diseases Leukaemia

Hematology and hematologic malignancies Pathology

Kelvin P Lee

CD28-Mediated Regulation of Multiple Myeloma Cell Proliferation and Survival

Multiple myeloma and immunoproliferative diseases

Hematology and hematologic malignancies Pathology

Antonio Fojo

Clinical, Basic, Translational and Kinetic Studies of Drug Action and Resistance

Prostate Multiple myeloma and immunoproliferative diseases Breast All cancers but non-melanoma skin cancer

Donna Reece

Expediting Patient-Oriented Research in Canada: Development of Myeloma Canada Research Network (MCRN)

Multiple myeloma and immunoproliferative diseases